home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Improvement of Risk-based Supplier Management System

 
  October 02, 2012  
     
 
ComplianceOnline, Online Event
2012-10-18


Why Should You Attend:

You depend on your suppliers, but can your system prove that you have sufficient control over, especially, your critical suppliers to assure auditors and regulatory agencies that your product is safe and meets all your requirements?

This presentation will provide an understanding of the two important guidelines now being used by FDA and ISO 13485 Notified Body auditors. This will allow you to make sure your supplier management and control system meets these guidelines, especially for outsourced processes including contract manufacturing, distribution, sterilization and testing.

In addition to defining the content of a supplier management program, the guidance documents require that you understand, define, document and control the risks related to all of your suppliers. This may include some of the supplies of your suppliers. Supplier control has always been an FDA and ISO 13485 requirement, but the current expectation is that you actually document this control as part of your supplier management program, and most supplier control programs have not done this in the past.

As regulatory bodies are getting more pressure on them from governments and the general public, they have to use the tools of auditing quality management systems to make sure that manufacturers’ are producing safe and effective medical devices. Since particularly the FDA, cannot require your suppliers to meet the same quality system regulations that you do, they must do as much as they can to make sure you are exercising sufficient control over your suppliers. This presentation will help you prepare for the current expectations for evaluating and controlling your suppliers.

Learning Objectives:

This webinar will provide valuable assistance in:

  • Developing or updating your supplier control system to one based on risk.
  • Complying with ever more stringent expectation of ISO 13485 auditors related to suppliers.
  • Understand the special requirements related to contract manufacturers, distributors, and other critical suppliers.
  • Determine different ways to assess suppliers based upon risk.
  • Learn the importance of developing solid contractual agreements with key suppliers.
  • Understand the importance of supplier quality and its relevance to ISO 13485 and FDA’s quality system requirements.
 
Event Details:
 
Date:                     October 18, 2012
Time:                    10:00 AM-11:30 AM PDT
Cost:                     $249 per attendee per computer terminal
Registration:          SIgn-Up on-line now.  Add to your shopping cart. 
 
 
Organized by: ComplianceOnline
Invited Speakers: Betty Lane, has over 30 years experience in Medical Device quality assurance and regulatory affairs. She is the founder and President of Be Quality Associates, LLC, a consulting company helping small and medium sized medical device and diagnostic companies implement and improve their quality systems for both FDA and ISO 13485 compliance band business when they became FDA and industry requirements. Her are areas of expertise include training, auditing, supplier management, design controls, software validation and general safety.
 
Deadline for Abstracts: 2012-10-18
 
Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=702501?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.